Id |
Subject |
Object |
Predicate |
Lexical cue |
T130 |
0-187 |
Sentence |
denotes |
Protease activation on S protein is an important step for coronavirus entry, and cathepsins in lysosome have been shown to be critical for SARS-CoV and MERS-CoV entry through endocytosis. |
T131 |
188-435 |
Sentence |
denotes |
To investigate whether cathepsins are required for SARS-CoV-2 entry, HEK 293/hACE2 cells were treated with either a broad inhibitor for cathepsin B, H, L, and calpain (E64D), cathepsin L inhibitor (SID 26681509), or cathepsin B inhibitor (CA-074). |
T132 |
436-562 |
Sentence |
denotes |
VSV-G pseudovirions were used as a negative control, since virus entry mediated by VSV-G does not require protease activation. |
T133 |
563-754 |
Sentence |
denotes |
E64D treatment of 293/hACE2 cells reduced entry of SARS-CoV-2 S pseudovirions by 92.5%, indicating that at least one of cathepsins or calpain might be required for SARS-CoV-2 entry (Fig. 4a). |
T134 |
755-1084 |
Sentence |
denotes |
While cathepsin B inhibitor treatment did not show any marked effect on virus entry, cathepsin L inhibition treatment decreased entry of SARS-CoV-2 S pseudovirions into 293/hACE2 by over 76% (Fig. 4a), suggesting that cathepsin L should be essential for priming of SARS-CoV-2 S protein in lysosome for entry into 293/hACE2 cells. |
T135 |
1085-1152 |
Sentence |
denotes |
Fig. 4 Activation of SARS-CoV-2 S protein by cathepsin and trypsin. |
T136 |
1153-1245 |
Sentence |
denotes |
a Effects of cathepsin inhibitors on entry of SARS-CoV-2 S pseudovirions on 293/hACE2 cells. |
T137 |
1246-1480 |
Sentence |
denotes |
HEK 293/hACE2 cells were pretreated with broad-spectrum cathepsin inhibitor E64D, cathepsin L-specific inhibitor (SID 26681509), or cathepsin B-specific inhibitor (CA-074) and then transduced with SARS-CoV-2 S and VSV-G pseudovirions. |
T138 |
1481-1544 |
Sentence |
denotes |
Pseudoviral transduction was measured at 40 h post inoculation. |
T139 |
1545-1616 |
Sentence |
denotes |
Experiments were done in triplicates and repeated at least three times. |
T140 |
1617-1645 |
Sentence |
denotes |
One representative is shown. |
T141 |
1646-1748 |
Sentence |
denotes |
Error bars indicate SEM of technical triplicates. b Cell–cell fusion mediated by SARS-CoV-2 S protein. |
T142 |
1749-1945 |
Sentence |
denotes |
HEK 293T cells were transiently expressing eGFP and either SARS-CoV-2 or SARS-CoV S protein were detached with either trypsin or EDTA, and co-cultured with 293/hACE2 or 293 cells for 4 h at 37 °C. |
T143 |
1946-2242 |
Sentence |
denotes |
The scale bar indicates 250 µm. c Quantitative analysis of syncytia in panel b. d, e Thermostability analysis of SARS-CoV-2 S protein. d SARS-CoV and SARS-CoV-2 S pseudovirons were incubated at 37 °C for the specified times (0 to 4 h) in the absence of serum, and then assayed on 293/hACE2 cells. |
T144 |
2243-2545 |
Sentence |
denotes |
The results from infection at 0 h were set as 100%, and the experiments were repeated four times, and means with standard deviations are shown. e SARS-CoV and SARS-CoV-2 S pseudovirions without serum were incubated at the indicated temperature (37 to 51 °C) for 2 h and then assayed on 293/hACE2 cells. |
T145 |
2546-2614 |
Sentence |
denotes |
The results are reported as the percentage of transduction at 37 °C. |
T146 |
2615-2702 |
Sentence |
denotes |
The experiments were repeated four times, and means with standard deviations are shown. |
T147 |
2703-2750 |
Sentence |
denotes |
Source data are provided as a Source Data file. |